Patents by Inventor Zhenglin Yang

Zhenglin Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240189924
    Abstract: A cutting body for a drilling tool has a center axis, at least one cutting element with at least one cutting edge, and at least one side face. The at least one side face has at least one radially inwardly directed cutout, which is designed to produce a drilled hole having an increased roughness, the cutout having precisely three open sides.
    Type: Application
    Filed: March 11, 2022
    Publication date: June 13, 2024
    Inventors: Haifeng Ji, Zhenglin Yang, Fabian Geissmann, Andrea Pedretti, Long Zhou, Massimo Anghileri, Sonia Wang
  • Patent number: 11795509
    Abstract: A screening kit for paroxysmal supraventricular tachycardia contains a reagent for detecting a human CACNA1B gene c. 1700A>G mutation site at base No. 1700 in a coding region of CACNA1B gene from A to G.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: October 24, 2023
    Assignees: SICHUAN PROVINCIAL PEOPLE'S HOSPITAL, CHENGDU MEDICAL COLLEGE, NANJING YSY BIOTECH COMPANY LTD.
    Inventors: Xiaoping Li, Rong Luo, Qingshun Zhao, Zhenglin Yang, Tao He, Mingjiang Liu
  • Publication number: 20230057598
    Abstract: A screening kit for paroxysmal supraventricular tachycardia contains a reagent for detecting a human CACNA1B gene c. 1700A>G mutation site at base No. 1700 in a coding region of CACNA1B gene from A to G.
    Type: Application
    Filed: September 10, 2020
    Publication date: February 23, 2023
    Inventors: Xiaoping LI, Rong LUO, Qingshun ZHAO, Zhenglin YANG, Tao HE, Mingjiang LIU
  • Publication number: 20220049310
    Abstract: The present disclosure discloses a use of a ZNF124 gene in early screening or auxiliary diagnosis of retinitis pigmentosa disease. The present disclosure also discloses a use of a detection reagent for detecting ZNF124 gene mutation in preparation of a reagent or a kit for early screening or auxiliary diagnosis of the retinitis pigmentosa disease. Research of the present disclosure finds that the mutation of the ZNF124 gene is related to the retinitis pigmentosa disease, early screening or auxiliary diagnosis can be performed on the retinitis pigmentosa disease by detecting the mutation of the ZNF124 gene.
    Type: Application
    Filed: October 20, 2020
    Publication date: February 17, 2022
    Inventors: Xianjun Zhu, Zhenglin Yang, Yeming Yang, Wanli Tian, Wenjing Liu
  • Patent number: 11209507
    Abstract: The present application provides a switching power supply and a magnetic resonance imaging system. The switching power supply is used for supplying power to a radio frequency coil control device, wherein the radio frequency coil control device is used for controlling a flow direction of radio frequency power output by a radio frequency amplifier of the magnetic resonance imaging system. Moreover, the switching power supply comprises a first power unit, a second power unit, and an air-cored transformer, the second power unit and the first power unit being electrically coupled through the air-cored transformer, wherein the switching power supply is configured to operate at a preset frequency, and frequency multiplication of the preset frequency is beyond a reception bandwidth of the magnetic resonance imaging system.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: December 28, 2021
    Assignee: GE PRECISION HEALTHCARE LLC
    Inventors: Hong Gu, Zhenglin Yang, Yanan Chen, Haiyuan Sun, Yang Chen
  • Publication number: 20200375157
    Abstract: Provided is a construction method for an animal model for retinitis pigmentosa diseases and the application thereof, which relate to the technical field of medical engineering. According to the construction method for the animal model for retinitis pigmentosa diseases, by knocking out Hkdc1 gene sequences on genomes of target animals, the animal model for retinitis pigmentosa diseases is obtained. The animal model presents typical characteristics of retinitis pigmentosa, such as retina function damage and gradual apoptosis of photoreceptor cells. The animal model can be applied to research of retinitis pigmentosa diseases and for to screening medicine for the treatment of retinitis pigmentosa diseases.
    Type: Application
    Filed: November 30, 2018
    Publication date: December 3, 2020
    Inventors: Xianjun ZHU, Zhenglin YANG, Lin ZHANG, Yeming YANG
  • Publication number: 20200200845
    Abstract: The present application provides a switching power supply and a magnetic resonance imaging system. The switching power supply is used for supplying power to a radio frequency coil control device, wherein the radio frequency coil control device is used for controlling a flow direction of radio frequency power output by a radio frequency amplifier of the magnetic resonance imaging system. Moreover, the switching power supply comprises a first power unit, a second power unit, and an air-cored transformer, the second power unit and the first power unit being electrically coupled through the air-cored transformer, wherein the switching power supply is configured to operate at a preset frequency, and frequency multiplication of the preset frequency is beyond a reception bandwidth of the magnetic resonance imaging system.
    Type: Application
    Filed: December 17, 2019
    Publication date: June 25, 2020
    Inventors: Hong GU, Zhenglin YANG, Yanan CHEN, Haiyuan SUN, Yang CHEN
  • Publication number: 20170058047
    Abstract: Methods of detecting and treating diseases and pathological conditions of the eye are disclosed. In particular a genetic variant of the HtrA1 gene is correlated to age related macular degeneration (AMD). In addition, biologically active agents capable of inhibiting HtrA1 activity are provided, and methods of treating diseases and pathological conditions of the eye are additionally disclosed.
    Type: Application
    Filed: April 6, 2016
    Publication date: March 2, 2017
    Applicant: University of Utah Research Foundation
    Inventors: Kang Zhang, Zhenglin Yang, Haoyu Chen, Dean Li
  • Publication number: 20170051075
    Abstract: Ocular diseases affecting the macula or the vasculature of the eye affect a wide variety of individuals. In particular, Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world and has a significant genetic predisposition. Methods of analyzing one or more mutations in the HtrA1 gene in order to identify individuals with a presusceptability to development of an ocular disease and a pathologic condition of the eye and diagnose those currently suffering from an ocular disease or a pathologic condition of the eye are provided. The methods of the present invention may further include analysis of the CFH gene in order to identify individuals with a presusceptability to development of an ocular disease and a pathologic condition of the eye and diagnose those currently suffering from an ocular disease or a pathologic condition of the eye. Compositions and methods for treating ocular disease and pathologic conditions of the eye are also provided.
    Type: Application
    Filed: April 6, 2016
    Publication date: February 23, 2017
    Applicant: University of Utah Research Foundation
    Inventors: Kang Zhang, Zhenglin Yang, Haoyu Chen, Dean Li
  • Publication number: 20100267576
    Abstract: Disclosed herein are compositions and methods for the identification of a subject at risk for developing type 2 diabetes. Also disclosed is a therapeutic target for the prevention and treatment of type 2 diabetes.
    Type: Application
    Filed: May 2, 2008
    Publication date: October 21, 2010
    Applicants: University of Utah Research foundation, The John Hopkins University
    Inventors: Kang Zhang, Zhenglin Yang, Jantje M. Gerdes, Nicholas Katsanis